Cibus Q1 net loss narrows to $21.2M; Rice HT U.S. launch pushed to 2029

Cibus, Inc.

2026-Q1 EPS reported -$0.33 revenue$1,681,000

Net loss of $21.2M ($0.33/share) vs $49.4M ($1.34) in Q1 2025; no goodwill impairment this quarter.
Cash at $30.3M; net cash usage guidance of ~$30M or less in 2026.
Rice HT program: U.S. launch rescheduled to 2029 due to herbicide registration delay; LATAM launch still targeted for 2027.
Q1 revenue increased YoY; R&D down 26% to $8.7M, SG&A down 48% to $5.1M on cost cuts.
Raised ~$37.3M in two equity offerings YTD 2026; Thomas Urban appointed to Board.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.